Department of Medicine, University of California San Francisco, San Francisco, California 94143-1270, USA.
J Virol. 2011 Feb;85(4):1696-705. doi: 10.1128/JVI.01120-10. Epub 2010 Dec 8.
HIV replication is suppressed in vitro by a CD8(+) cell noncytotoxic antiviral response (CNAR). This activity directly correlates with an asymptomatic clinical state. The objective of this study was to identify the phenotype of CD8(+) cell subsets having strong CNAR activity. CD8(+) cell subset frequencies and CNAR levels were measured for human immunodeficiency virus (HIV)-uninfected individuals and three groups of HIV type 1 (HIV-1)-infected individuals: asymptomatic individuals with low-level viremia (vHIV), antiretroviral-drug-treated subjects with undetectable virus levels (TxHIV), and therapy-naïve aviremic elite controllers (EC). CD8(+) cells from the vHIV individuals exhibited the highest HIV-suppressing activity and had elevated frequencies of CD45RA(-) CD27(+) and PD-1(+) (CD279(+)) cells. Functional assessments of CD8(+) cells sorted into distinct subsets established that maximal CNAR activity was mediated by CD45RA(-) CCR7(-) CD27(+) and PD-1(+) CD8(+) cells. T cell receptor (TCR) repertoire profiles of CD8(+) cell subsets having strong CNAR activity exhibited increased perturbations in comparison to those of inactive subsets. Together, these studies suggest that CNAR is driven by HIV replication and that this antiviral activity is associated with oligoclonally expanded activated CD8(+) cells expressing PD-1 and having a transitional memory cell phenotype. The findings better describe the identity of CD8(+) cells showing CNAR and should facilitate the evaluation of this important immune response in studies of HIV pathogenesis, resistance to infection, and vaccine development.
HIV 在体外的复制受到 CD8(+) 细胞非细胞毒性抗病毒反应 (CNAR) 的抑制。这种活性与无症状的临床状态直接相关。本研究的目的是确定具有强 CNAR 活性的 CD8(+)细胞亚群的表型。测量了人类免疫缺陷病毒 (HIV) 未感染个体以及三组 HIV 型 1 (HIV-1) 感染个体的 CD8(+)细胞亚群频率和 CNAR 水平:低病毒载量的无症状个体 (vHIV)、抗病毒药物治疗病毒水平不可检测的个体 (TxHIV) 和未经治疗的无病毒精英控制器 (EC)。vHIV 个体的 CD8(+)细胞表现出最高的 HIV 抑制活性,并且具有升高的 CD45RA(-)CD27(+)和 PD-1(+)(CD279(+))细胞频率。对不同亚群的 CD8(+)细胞进行的功能评估表明,最大的 CNAR 活性是由 CD45RA(-)CCR7(-)CD27(+)和 PD-1(+)CD8(+)细胞介导的。与非活性亚群相比,具有强 CNAR 活性的 CD8(+)细胞亚群的 T 细胞受体 (TCR) 谱特征显示出更大的扰动。这些研究表明,CNAR 是由 HIV 复制驱动的,这种抗病毒活性与表达 PD-1 并具有过渡性记忆细胞表型的寡克隆扩增激活 CD8(+)细胞有关。这些发现更好地描述了表现出 CNAR 的 CD8(+)细胞的特性,并应有助于评估这种重要免疫反应在 HIV 发病机制、感染抵抗和疫苗开发研究中的作用。